Villadar, Eufemia R.

HRN: 23-51-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2023
08/15/2023
IVT
1.5gms
Q8
Minimal Pleural Effussion Sec To Lung Ca
Waiting Final Action 
08/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2023
08/15/2023
IVT
1.5gms
Q8
Minimal Pleural Effussion Sec To Lung Ca
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: